Cargando…

Nrf2 induces malignant transformation of hepatic progenitor cells by inducing β-catenin expression

The Nrf2 signaling pathway prevents cancer initiation, but genetic mutations that activate this pathway are found in various types of cancer. The molecular mechanisms underlying this Janus-headed character are still not understood. Here, we show that sustained Nrf2 activation induces proliferation a...

Descripción completa

Detalles Bibliográficos
Autores principales: Fragoulis, Athanassios, Schenkel, Julia, Schröder, Nicole, Brandt, Elisa Fabiana, Weiand, Mathias, Neu, Tabita, Ramadori, Pierluigi, Caspers, Tim, Kant, Sebastian, Pufe, Thomas, Mohs, Antje, Trautwein, Christian, Longerich, Thomas, Streetz, Konrad Ludwig, Wruck, Christoph Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618468/
https://www.ncbi.nlm.nih.gov/pubmed/36209041
http://dx.doi.org/10.1016/j.redox.2022.102453
_version_ 1784821056507215872
author Fragoulis, Athanassios
Schenkel, Julia
Schröder, Nicole
Brandt, Elisa Fabiana
Weiand, Mathias
Neu, Tabita
Ramadori, Pierluigi
Caspers, Tim
Kant, Sebastian
Pufe, Thomas
Mohs, Antje
Trautwein, Christian
Longerich, Thomas
Streetz, Konrad Ludwig
Wruck, Christoph Jan
author_facet Fragoulis, Athanassios
Schenkel, Julia
Schröder, Nicole
Brandt, Elisa Fabiana
Weiand, Mathias
Neu, Tabita
Ramadori, Pierluigi
Caspers, Tim
Kant, Sebastian
Pufe, Thomas
Mohs, Antje
Trautwein, Christian
Longerich, Thomas
Streetz, Konrad Ludwig
Wruck, Christoph Jan
author_sort Fragoulis, Athanassios
collection PubMed
description The Nrf2 signaling pathway prevents cancer initiation, but genetic mutations that activate this pathway are found in various types of cancer. The molecular mechanisms underlying this Janus-headed character are still not understood. Here, we show that sustained Nrf2 activation induces proliferation and dedifferentiation of a Wnt-responsive perivenular hepatic progenitor cell population, transforming them into metastatic cancer cells. The neoplastic lesions display many histological features known from human hepatoblastoma. We describe an Nrf2-induced upregulation of β-catenin expression and its activation as the underlying mechanism for the observed malignant transformation. Thus, we have identified the Nrf2–β-catenin axis promoting proliferation of hepatic stem cells and triggering tumorigenesis. These findings support the concept that different functional levels of Nrf2 control both the protection against various toxins as well as liver regeneration by activating hepatic stem cells. Activation of the hepatic stem cell compartment confers the observation that unbridled Nrf2 activation may trigger tumorigenesis.
format Online
Article
Text
id pubmed-9618468
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-96184682022-11-01 Nrf2 induces malignant transformation of hepatic progenitor cells by inducing β-catenin expression Fragoulis, Athanassios Schenkel, Julia Schröder, Nicole Brandt, Elisa Fabiana Weiand, Mathias Neu, Tabita Ramadori, Pierluigi Caspers, Tim Kant, Sebastian Pufe, Thomas Mohs, Antje Trautwein, Christian Longerich, Thomas Streetz, Konrad Ludwig Wruck, Christoph Jan Redox Biol Articles from the Special Issue on Redox Modulation of Cancer Heterogeneity, Therapeutic Resistance and Immunotherapy Efficacy; Edited by Dr. Anita Hjelmeland The Nrf2 signaling pathway prevents cancer initiation, but genetic mutations that activate this pathway are found in various types of cancer. The molecular mechanisms underlying this Janus-headed character are still not understood. Here, we show that sustained Nrf2 activation induces proliferation and dedifferentiation of a Wnt-responsive perivenular hepatic progenitor cell population, transforming them into metastatic cancer cells. The neoplastic lesions display many histological features known from human hepatoblastoma. We describe an Nrf2-induced upregulation of β-catenin expression and its activation as the underlying mechanism for the observed malignant transformation. Thus, we have identified the Nrf2–β-catenin axis promoting proliferation of hepatic stem cells and triggering tumorigenesis. These findings support the concept that different functional levels of Nrf2 control both the protection against various toxins as well as liver regeneration by activating hepatic stem cells. Activation of the hepatic stem cell compartment confers the observation that unbridled Nrf2 activation may trigger tumorigenesis. Elsevier 2022-09-13 /pmc/articles/PMC9618468/ /pubmed/36209041 http://dx.doi.org/10.1016/j.redox.2022.102453 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Articles from the Special Issue on Redox Modulation of Cancer Heterogeneity, Therapeutic Resistance and Immunotherapy Efficacy; Edited by Dr. Anita Hjelmeland
Fragoulis, Athanassios
Schenkel, Julia
Schröder, Nicole
Brandt, Elisa Fabiana
Weiand, Mathias
Neu, Tabita
Ramadori, Pierluigi
Caspers, Tim
Kant, Sebastian
Pufe, Thomas
Mohs, Antje
Trautwein, Christian
Longerich, Thomas
Streetz, Konrad Ludwig
Wruck, Christoph Jan
Nrf2 induces malignant transformation of hepatic progenitor cells by inducing β-catenin expression
title Nrf2 induces malignant transformation of hepatic progenitor cells by inducing β-catenin expression
title_full Nrf2 induces malignant transformation of hepatic progenitor cells by inducing β-catenin expression
title_fullStr Nrf2 induces malignant transformation of hepatic progenitor cells by inducing β-catenin expression
title_full_unstemmed Nrf2 induces malignant transformation of hepatic progenitor cells by inducing β-catenin expression
title_short Nrf2 induces malignant transformation of hepatic progenitor cells by inducing β-catenin expression
title_sort nrf2 induces malignant transformation of hepatic progenitor cells by inducing β-catenin expression
topic Articles from the Special Issue on Redox Modulation of Cancer Heterogeneity, Therapeutic Resistance and Immunotherapy Efficacy; Edited by Dr. Anita Hjelmeland
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618468/
https://www.ncbi.nlm.nih.gov/pubmed/36209041
http://dx.doi.org/10.1016/j.redox.2022.102453
work_keys_str_mv AT fragoulisathanassios nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression
AT schenkeljulia nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression
AT schrodernicole nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression
AT brandtelisafabiana nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression
AT weiandmathias nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression
AT neutabita nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression
AT ramadoripierluigi nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression
AT casperstim nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression
AT kantsebastian nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression
AT pufethomas nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression
AT mohsantje nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression
AT trautweinchristian nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression
AT longerichthomas nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression
AT streetzkonradludwig nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression
AT wruckchristophjan nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression